David Gobel
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Mr. David Gobel is an Independent Director at VivoSim Labs, Inc., a Chairman at Turn Biotechnologies, Inc., a Chief Executive Officer at Methuselah Capital Management LLC, a Chief Executive Officer at Methuselah Funds LLC, an Independent Director at Oisin Biotechnologies, Inc. and a Chief Executive Officer at Methuselah Foundation.
He is on the Board of Directors at VivoSim Labs, Inc., Leucadia Therapeutics, Inc. and Oisin Biotechnologies, Inc. Mr. Gobel was previously employed as a Chief Venture Strategist by Transportation Security Administration.
He also served on the board at Volumetric Biotechnologies, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIVOSIM LABS INC -.--% | 15/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VIVOSIM LABS, INC. | Directeur/Membre du Conseil | 15/09/2020 |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Directeur/Membre du Conseil | 01/12/2014 |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Directeur Général | 01/01/2017 |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Directeur/Membre du Conseil | 01/10/2015 |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Directeur Général | 01/09/2001 |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Président | 01/05/2020 |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Directeur Général | 01/12/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
Volumetric Biotechnologies, Inc. | Directeur/Membre du Conseil | 01/01/2020 |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Corporate Officer/Principal | 01/03/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
VivoSim Labs, Inc.
VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Government |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Miscellaneous |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Health Technology |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Volumetric Biotechnologies, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national